Evasion of host immune defenses by human papillomavirus
•HPV dysregulates various molecular and cellular pathways to evade host defenses.•HPV alters transcription of key immune modulators.•HPV E6 and E7 interacts with core proteins of the interferon pathway.•HPV E5 and E7 downregulate surface expression of MHC molecules.•Papillomavirus genome evolution m...
Gespeichert in:
Veröffentlicht in: | Virus research 2017-03, Vol.231, p.21-33 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 33 |
---|---|
container_issue | |
container_start_page | 21 |
container_title | Virus research |
container_volume | 231 |
creator | Westrich, Joseph A. Warren, Cody J. Pyeon, Dohun |
description | •HPV dysregulates various molecular and cellular pathways to evade host defenses.•HPV alters transcription of key immune modulators.•HPV E6 and E7 interacts with core proteins of the interferon pathway.•HPV E5 and E7 downregulate surface expression of MHC molecules.•Papillomavirus genome evolution may be driven by virus evasion of host restriction.
A majority of human papillomavirus (HPV) infections are asymptomatic and self-resolving in the absence of medical interventions. Various innate and adaptive immune responses, as well as physical barriers, have been implicated in controlling early HPV infections. However, if HPV overcomes these host immune defenses and establishes persistence in basal keratinocytes, it becomes very difficult for the host to eliminate the infection. The HPV oncoproteins E5, E6, and E7 are important in regulating host immune responses. These oncoproteins dysregulate gene expression, protein–protein interactions, posttranslational modifications, and cellular trafficking of critical host immune modulators. In addition to the HPV oncoproteins, sequence variation and dinucleotide depletion in papillomavirus genomes has been suggested as an alternative strategy for evasion of host immune defenses. Since anti-HPV host immune responses are also considered to be important for antitumor immunity, immune dysregulation by HPV during virus persistence may contribute to immune suppression essential for HPV-associated cancer progression. Here, we discuss cellular pathways dysregulated by HPV that allow the virus to evade various host immune defenses. |
doi_str_mv | 10.1016/j.virusres.2016.11.023 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5325784</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168170216305627</els_id><sourcerecordid>1844353816</sourcerecordid><originalsourceid>FETCH-LOGICAL-c504t-f1ad49afb2c0d0df0e26c842a2216ea5deef4ecb0348a7008a93252271fb53f73</originalsourceid><addsrcrecordid>eNqFkU1PwzAMhiMEgjH4C6hHLi35apNeEAiNDwmJC5yjNHVYprYZSTuJf09gDMGJk2P59WvHD0JnBBcEk-piVWxcmGKAWNCUF4QUmLI9NCNS0Fzwmu6jWSrInAhMj9BxjCuMccVEdYiOqJB1epMZEouNjs4PmbfZ0scxc30_DZC1YGGIELPmPVtOvR6ytV67rvO9_hp8gg6s7iKcfsc5erldPN_c549Pdw8314-5KTEfc0t0y2ttG2pwi1uLgVZGcqopJRXosgWwHEyDGZdaYCx1zWhJqSC2KZkVbI4ut77rqemhNTCMQXdqHVyvw7vy2qm_lcEt1avfqDL5CMmTwfm3QfBvE8RR9S4a6Do9gJ-ioukqJa1YLf-VEsk5K5kkVZJWW6kJPiYK9mcjgtUnILVSO0DqE5AiRCVAqfHs939-2nZEkuBqK4B01Y2DoKJxMBhoXQAzqta7_2Z8AM4IprU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1844353816</pqid></control><display><type>article</type><title>Evasion of host immune defenses by human papillomavirus</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Westrich, Joseph A. ; Warren, Cody J. ; Pyeon, Dohun</creator><creatorcontrib>Westrich, Joseph A. ; Warren, Cody J. ; Pyeon, Dohun</creatorcontrib><description>•HPV dysregulates various molecular and cellular pathways to evade host defenses.•HPV alters transcription of key immune modulators.•HPV E6 and E7 interacts with core proteins of the interferon pathway.•HPV E5 and E7 downregulate surface expression of MHC molecules.•Papillomavirus genome evolution may be driven by virus evasion of host restriction.
A majority of human papillomavirus (HPV) infections are asymptomatic and self-resolving in the absence of medical interventions. Various innate and adaptive immune responses, as well as physical barriers, have been implicated in controlling early HPV infections. However, if HPV overcomes these host immune defenses and establishes persistence in basal keratinocytes, it becomes very difficult for the host to eliminate the infection. The HPV oncoproteins E5, E6, and E7 are important in regulating host immune responses. These oncoproteins dysregulate gene expression, protein–protein interactions, posttranslational modifications, and cellular trafficking of critical host immune modulators. In addition to the HPV oncoproteins, sequence variation and dinucleotide depletion in papillomavirus genomes has been suggested as an alternative strategy for evasion of host immune defenses. Since anti-HPV host immune responses are also considered to be important for antitumor immunity, immune dysregulation by HPV during virus persistence may contribute to immune suppression essential for HPV-associated cancer progression. Here, we discuss cellular pathways dysregulated by HPV that allow the virus to evade various host immune defenses.</description><identifier>ISSN: 0168-1702</identifier><identifier>EISSN: 1872-7492</identifier><identifier>DOI: 10.1016/j.virusres.2016.11.023</identifier><identifier>PMID: 27890631</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adaptive Immunity ; APOBEC Deaminases ; APOBEC3 ; Cytidine Deaminase ; Cytosine Deaminase - genetics ; Cytosine Deaminase - immunology ; disease course ; DNA Methylation ; gene expression ; Gene Expression Regulation ; genome ; Genome, Viral ; Histone modification ; Histones - genetics ; Histones - immunology ; HPV ; Humans ; Immune Evasion ; immune response ; Immunity, Innate ; immunomodulators ; Innate immunity ; keratinocytes ; Keratinocytes - immunology ; Keratinocytes - virology ; medical treatment ; neoplasms ; NF-kappa B - genetics ; NF-kappa B - immunology ; Oncogene ; oncogene proteins ; Oncogene Proteins, Viral - genetics ; Oncogene Proteins, Viral - immunology ; Papillomaviridae ; Papillomaviridae - genetics ; Papillomaviridae - growth & development ; Papillomaviridae - pathogenicity ; Papillomavirus ; Papillomavirus Infections - genetics ; Papillomavirus Infections - immunology ; Papillomavirus Infections - pathology ; Papillomavirus Infections - virology ; post-translational modification ; protein-protein interactions ; Restriction factor ; sequence diversity ; Tumor virus ; Virion - genetics ; Virion - growth & development ; Virion - pathogenicity ; Virus evolution ; Virus Replication ; viruses</subject><ispartof>Virus research, 2017-03, Vol.231, p.21-33</ispartof><rights>2016 The Authors</rights><rights>Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c504t-f1ad49afb2c0d0df0e26c842a2216ea5deef4ecb0348a7008a93252271fb53f73</citedby><cites>FETCH-LOGICAL-c504t-f1ad49afb2c0d0df0e26c842a2216ea5deef4ecb0348a7008a93252271fb53f73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0168170216305627$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27890631$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Westrich, Joseph A.</creatorcontrib><creatorcontrib>Warren, Cody J.</creatorcontrib><creatorcontrib>Pyeon, Dohun</creatorcontrib><title>Evasion of host immune defenses by human papillomavirus</title><title>Virus research</title><addtitle>Virus Res</addtitle><description>•HPV dysregulates various molecular and cellular pathways to evade host defenses.•HPV alters transcription of key immune modulators.•HPV E6 and E7 interacts with core proteins of the interferon pathway.•HPV E5 and E7 downregulate surface expression of MHC molecules.•Papillomavirus genome evolution may be driven by virus evasion of host restriction.
A majority of human papillomavirus (HPV) infections are asymptomatic and self-resolving in the absence of medical interventions. Various innate and adaptive immune responses, as well as physical barriers, have been implicated in controlling early HPV infections. However, if HPV overcomes these host immune defenses and establishes persistence in basal keratinocytes, it becomes very difficult for the host to eliminate the infection. The HPV oncoproteins E5, E6, and E7 are important in regulating host immune responses. These oncoproteins dysregulate gene expression, protein–protein interactions, posttranslational modifications, and cellular trafficking of critical host immune modulators. In addition to the HPV oncoproteins, sequence variation and dinucleotide depletion in papillomavirus genomes has been suggested as an alternative strategy for evasion of host immune defenses. Since anti-HPV host immune responses are also considered to be important for antitumor immunity, immune dysregulation by HPV during virus persistence may contribute to immune suppression essential for HPV-associated cancer progression. Here, we discuss cellular pathways dysregulated by HPV that allow the virus to evade various host immune defenses.</description><subject>Adaptive Immunity</subject><subject>APOBEC Deaminases</subject><subject>APOBEC3</subject><subject>Cytidine Deaminase</subject><subject>Cytosine Deaminase - genetics</subject><subject>Cytosine Deaminase - immunology</subject><subject>disease course</subject><subject>DNA Methylation</subject><subject>gene expression</subject><subject>Gene Expression Regulation</subject><subject>genome</subject><subject>Genome, Viral</subject><subject>Histone modification</subject><subject>Histones - genetics</subject><subject>Histones - immunology</subject><subject>HPV</subject><subject>Humans</subject><subject>Immune Evasion</subject><subject>immune response</subject><subject>Immunity, Innate</subject><subject>immunomodulators</subject><subject>Innate immunity</subject><subject>keratinocytes</subject><subject>Keratinocytes - immunology</subject><subject>Keratinocytes - virology</subject><subject>medical treatment</subject><subject>neoplasms</subject><subject>NF-kappa B - genetics</subject><subject>NF-kappa B - immunology</subject><subject>Oncogene</subject><subject>oncogene proteins</subject><subject>Oncogene Proteins, Viral - genetics</subject><subject>Oncogene Proteins, Viral - immunology</subject><subject>Papillomaviridae</subject><subject>Papillomaviridae - genetics</subject><subject>Papillomaviridae - growth & development</subject><subject>Papillomaviridae - pathogenicity</subject><subject>Papillomavirus</subject><subject>Papillomavirus Infections - genetics</subject><subject>Papillomavirus Infections - immunology</subject><subject>Papillomavirus Infections - pathology</subject><subject>Papillomavirus Infections - virology</subject><subject>post-translational modification</subject><subject>protein-protein interactions</subject><subject>Restriction factor</subject><subject>sequence diversity</subject><subject>Tumor virus</subject><subject>Virion - genetics</subject><subject>Virion - growth & development</subject><subject>Virion - pathogenicity</subject><subject>Virus evolution</subject><subject>Virus Replication</subject><subject>viruses</subject><issn>0168-1702</issn><issn>1872-7492</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1PwzAMhiMEgjH4C6hHLi35apNeEAiNDwmJC5yjNHVYprYZSTuJf09gDMGJk2P59WvHD0JnBBcEk-piVWxcmGKAWNCUF4QUmLI9NCNS0Fzwmu6jWSrInAhMj9BxjCuMccVEdYiOqJB1epMZEouNjs4PmbfZ0scxc30_DZC1YGGIELPmPVtOvR6ytV67rvO9_hp8gg6s7iKcfsc5erldPN_c549Pdw8314-5KTEfc0t0y2ttG2pwi1uLgVZGcqopJRXosgWwHEyDGZdaYCx1zWhJqSC2KZkVbI4ut77rqemhNTCMQXdqHVyvw7vy2qm_lcEt1avfqDL5CMmTwfm3QfBvE8RR9S4a6Do9gJ-ioukqJa1YLf-VEsk5K5kkVZJWW6kJPiYK9mcjgtUnILVSO0DqE5AiRCVAqfHs939-2nZEkuBqK4B01Y2DoKJxMBhoXQAzqta7_2Z8AM4IprU</recordid><startdate>20170302</startdate><enddate>20170302</enddate><creator>Westrich, Joseph A.</creator><creator>Warren, Cody J.</creator><creator>Pyeon, Dohun</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><scope>5PM</scope></search><sort><creationdate>20170302</creationdate><title>Evasion of host immune defenses by human papillomavirus</title><author>Westrich, Joseph A. ; Warren, Cody J. ; Pyeon, Dohun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c504t-f1ad49afb2c0d0df0e26c842a2216ea5deef4ecb0348a7008a93252271fb53f73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adaptive Immunity</topic><topic>APOBEC Deaminases</topic><topic>APOBEC3</topic><topic>Cytidine Deaminase</topic><topic>Cytosine Deaminase - genetics</topic><topic>Cytosine Deaminase - immunology</topic><topic>disease course</topic><topic>DNA Methylation</topic><topic>gene expression</topic><topic>Gene Expression Regulation</topic><topic>genome</topic><topic>Genome, Viral</topic><topic>Histone modification</topic><topic>Histones - genetics</topic><topic>Histones - immunology</topic><topic>HPV</topic><topic>Humans</topic><topic>Immune Evasion</topic><topic>immune response</topic><topic>Immunity, Innate</topic><topic>immunomodulators</topic><topic>Innate immunity</topic><topic>keratinocytes</topic><topic>Keratinocytes - immunology</topic><topic>Keratinocytes - virology</topic><topic>medical treatment</topic><topic>neoplasms</topic><topic>NF-kappa B - genetics</topic><topic>NF-kappa B - immunology</topic><topic>Oncogene</topic><topic>oncogene proteins</topic><topic>Oncogene Proteins, Viral - genetics</topic><topic>Oncogene Proteins, Viral - immunology</topic><topic>Papillomaviridae</topic><topic>Papillomaviridae - genetics</topic><topic>Papillomaviridae - growth & development</topic><topic>Papillomaviridae - pathogenicity</topic><topic>Papillomavirus</topic><topic>Papillomavirus Infections - genetics</topic><topic>Papillomavirus Infections - immunology</topic><topic>Papillomavirus Infections - pathology</topic><topic>Papillomavirus Infections - virology</topic><topic>post-translational modification</topic><topic>protein-protein interactions</topic><topic>Restriction factor</topic><topic>sequence diversity</topic><topic>Tumor virus</topic><topic>Virion - genetics</topic><topic>Virion - growth & development</topic><topic>Virion - pathogenicity</topic><topic>Virus evolution</topic><topic>Virus Replication</topic><topic>viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Westrich, Joseph A.</creatorcontrib><creatorcontrib>Warren, Cody J.</creatorcontrib><creatorcontrib>Pyeon, Dohun</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Virus research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Westrich, Joseph A.</au><au>Warren, Cody J.</au><au>Pyeon, Dohun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evasion of host immune defenses by human papillomavirus</atitle><jtitle>Virus research</jtitle><addtitle>Virus Res</addtitle><date>2017-03-02</date><risdate>2017</risdate><volume>231</volume><spage>21</spage><epage>33</epage><pages>21-33</pages><issn>0168-1702</issn><eissn>1872-7492</eissn><abstract>•HPV dysregulates various molecular and cellular pathways to evade host defenses.•HPV alters transcription of key immune modulators.•HPV E6 and E7 interacts with core proteins of the interferon pathway.•HPV E5 and E7 downregulate surface expression of MHC molecules.•Papillomavirus genome evolution may be driven by virus evasion of host restriction.
A majority of human papillomavirus (HPV) infections are asymptomatic and self-resolving in the absence of medical interventions. Various innate and adaptive immune responses, as well as physical barriers, have been implicated in controlling early HPV infections. However, if HPV overcomes these host immune defenses and establishes persistence in basal keratinocytes, it becomes very difficult for the host to eliminate the infection. The HPV oncoproteins E5, E6, and E7 are important in regulating host immune responses. These oncoproteins dysregulate gene expression, protein–protein interactions, posttranslational modifications, and cellular trafficking of critical host immune modulators. In addition to the HPV oncoproteins, sequence variation and dinucleotide depletion in papillomavirus genomes has been suggested as an alternative strategy for evasion of host immune defenses. Since anti-HPV host immune responses are also considered to be important for antitumor immunity, immune dysregulation by HPV during virus persistence may contribute to immune suppression essential for HPV-associated cancer progression. Here, we discuss cellular pathways dysregulated by HPV that allow the virus to evade various host immune defenses.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>27890631</pmid><doi>10.1016/j.virusres.2016.11.023</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0168-1702 |
ispartof | Virus research, 2017-03, Vol.231, p.21-33 |
issn | 0168-1702 1872-7492 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5325784 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adaptive Immunity APOBEC Deaminases APOBEC3 Cytidine Deaminase Cytosine Deaminase - genetics Cytosine Deaminase - immunology disease course DNA Methylation gene expression Gene Expression Regulation genome Genome, Viral Histone modification Histones - genetics Histones - immunology HPV Humans Immune Evasion immune response Immunity, Innate immunomodulators Innate immunity keratinocytes Keratinocytes - immunology Keratinocytes - virology medical treatment neoplasms NF-kappa B - genetics NF-kappa B - immunology Oncogene oncogene proteins Oncogene Proteins, Viral - genetics Oncogene Proteins, Viral - immunology Papillomaviridae Papillomaviridae - genetics Papillomaviridae - growth & development Papillomaviridae - pathogenicity Papillomavirus Papillomavirus Infections - genetics Papillomavirus Infections - immunology Papillomavirus Infections - pathology Papillomavirus Infections - virology post-translational modification protein-protein interactions Restriction factor sequence diversity Tumor virus Virion - genetics Virion - growth & development Virion - pathogenicity Virus evolution Virus Replication viruses |
title | Evasion of host immune defenses by human papillomavirus |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T12%3A55%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evasion%20of%20host%20immune%20defenses%20by%20human%20papillomavirus&rft.jtitle=Virus%20research&rft.au=Westrich,%20Joseph%20A.&rft.date=2017-03-02&rft.volume=231&rft.spage=21&rft.epage=33&rft.pages=21-33&rft.issn=0168-1702&rft.eissn=1872-7492&rft_id=info:doi/10.1016/j.virusres.2016.11.023&rft_dat=%3Cproquest_pubme%3E1844353816%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1844353816&rft_id=info:pmid/27890631&rft_els_id=S0168170216305627&rfr_iscdi=true |